Abcombi Biosciences (ABI) is a pre-clinical vaccine and therapeutic development company delivering vaccine and anti-infective solutions. It provides a biofilm model that mimics the natural progression of the disease for colonizing bacteria. The company specializes in bioinformatics, polysaccharide conjugate vaccine manufacturing, and RNA-based therapy for treating influenza infections.